Type 2 diabetes — USMLE Step 3 MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Start a GLP-1 receptor agonist with cardiovascular benefit
In type 2 diabetes with established ASCVD, a GLP-1 receptor agonist with proven cardiovascular benefit is preferred as add-on therapy.
Reference: American Diabetes Association Standards of Care in Diabetes—2026